Bill Text: TX SB813 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to the prescribing of opioids.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Introduced - Dead) 2019-03-01 - Referred to Health & Human Services [SB813 Detail]
Download: Texas-2019-SB813-Introduced.html
| 86R11598 JSC-F | ||
| By: West | S.B. No. 813 | |
|
|
||
|
|
||
| relating to the prescribing of opioids. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Subchapter C, Chapter 481, Health and Safety | ||
| Code, is amended by adding Section 481.07635 to read as follows: | ||
| Sec. 481.07635. PRESCRIPTIONS OF OPIOIDS. (a) In this | ||
| section, "acute pain" means pain with abrupt onset that is caused by | ||
| an injury or other process that is not ongoing. | ||
| (b) For the initial treatment of acute pain, a prescriber | ||
| may not issue a prescription for an opioid in an amount that exceeds | ||
| a seven-day supply. | ||
| (c) On issuance of an initial opioid prescription under | ||
| Subsection (b) for a patient who is a minor, a prescriber shall | ||
| discuss with the patient and the patient's parent, conservator, or | ||
| guardian, or other person authorized to consent to the minor's | ||
| medical treatment: | ||
| (1) the risk of addiction and overdose associated with | ||
| the use of opioid prescription drugs; | ||
| (2) the danger of taking the drug with | ||
| benzodiazepines, alcohol, or other central nervous system | ||
| depressants; and | ||
| (3) the reasons why the prescription is necessary for | ||
| the patient. | ||
| (d) Notwithstanding Subsection (b), if, in the professional | ||
| medical judgment of a prescriber, more than a seven-day supply of an | ||
| opioid is required to treat the patient's acute pain or is necessary | ||
| for chronic pain management, for the treatment of pain associated | ||
| with a cancer diagnosis, or for palliative care, the practitioner | ||
| may issue a prescription for the quantity of the opioid needed to | ||
| treat the patient's pain. The prescriber shall document in the | ||
| patient's medical record: | ||
| (1) the specific medical condition that necessitated | ||
| greater than a seven-day supply of an opioid; and | ||
| (2) that in the prescriber's medical opinion, an | ||
| alternative non-opioid treatment was not appropriate to address the | ||
| medical condition. | ||
| (e) Subsection (b) does not apply to opioids prescribed to | ||
| treat substance abuse or opioid dependence. | ||
| (f) Before issuing any prescription for an opioid, a | ||
| prescriber shall: | ||
| (1) inform the patient that the patient has the option | ||
| of filling the prescription in a lesser quantity than that | ||
| prescribed; and | ||
| (2) inform the patient of the risks associated with | ||
| the opioid prescribed. | ||
| (g) At the request of the patient, a dispenser may dispense | ||
| an opioid in a quantity lower than the quantity listed on the | ||
| prescription. The dispenser may later fill the remaining quantity | ||
| of the prescription at the request of the patient. | ||
| (h) If the dispenser partially fills a prescription at the | ||
| request of a patient under Subsection (g), the dispenser shall | ||
| accurately record the amount dispensed in providing information to | ||
| the board. If the dispenser has access to the patient's electronic | ||
| health record, the dispenser shall also note the partial filling of | ||
| the prescription not later than the seventh day after the date the | ||
| opioid is dispensed. | ||
| (i) This section does not apply to a prescriber or dispenser | ||
| who is a veterinarian. | ||
| SECTION 2. Section 481.003(a), Health and Safety Code, is | ||
| amended to read as follows: | ||
| (a) The director may adopt rules to administer and enforce | ||
| this chapter, other than Sections 481.073, 481.074, 481.075, | ||
| 481.076, 481.0761, 481.0762, 481.0763, 481.07635, 481.0764, | ||
| 481.0765, and 481.0766. The board may adopt rules to administer | ||
| Sections 481.073, 481.074, 481.075, 481.076, 481.0761, 481.0762, | ||
| 481.0763, 481.07635, 481.0764, 481.0765, and 481.0766. | ||
| SECTION 3. Section 554.051(a-1), Occupations Code, is | ||
| amended to read as follows: | ||
| (a-1) The board may adopt rules to administer Sections | ||
| 481.073, 481.074, 481.075, 481.076, 481.0761, 481.0762, 481.0763, | ||
| 481.07635, 481.0764, 481.0765, and 481.0766, Health and Safety | ||
| Code. | ||
| SECTION 4. Section 565.003, Occupations Code, is amended to | ||
| read as follows: | ||
| Sec. 565.003. ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING | ||
| APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless | ||
| compliance would violate the pharmacy or drug statutes or rules in | ||
| the state in which the pharmacy is located, the board may discipline | ||
| an applicant for or the holder of a nonresident pharmacy license if | ||
| the board finds that the applicant or license holder has failed to | ||
| comply with: | ||
| (1) Section 481.073, 481.074, [ |
||
| 481.0761, 481.0762, 481.0763, 481.07635, 481.0764, 481.0765, or | ||
| 481.0766, Health and Safety Code; | ||
| (2) Texas substitution requirements regarding: | ||
| (A) the practitioner's directions concerning | ||
| generic substitution; | ||
| (B) the patient's right to refuse generic | ||
| substitution; or | ||
| (C) notification to the patient of the patient's | ||
| right to refuse substitution; | ||
| (3) any board rule relating to providing drug | ||
| information to the patient or the patient's agent in written form or | ||
| by telephone; or | ||
| (4) any board rule adopted under Section 554.051(a) | ||
| and determined by the board to be applicable under Section | ||
| 554.051(b). | ||
| SECTION 5. Section 481.07635, Health and Safety Code, as | ||
| added by this Act, applies only to a prescription issued on or after | ||
| the effective date of this Act. A prescription issued before the | ||
| effective date of this Act is governed by the law in effect on the | ||
| date the prescription is issued, and the former law is continued in | ||
| effect for that purpose. | ||
| SECTION 6. This Act takes effect September 1, 2019. | ||
